ANTIBIOTIC- ASSOCIATED RISK THE REDUCTION OF LACTOBACILLUS SPP. IN THE INTESTINAL MICROBIOTA IN PATIENTS WITH URINARY TRACT INFECTIONS

  • N. Stepanova SI «Institute of Nephrology NAMS of Ukraine»
  • N. Stashevska SI «Institute of Nephrology NAMS of Ukraine»
  • L. Lebid National Academy of Statistics, Accounting and Audit
  • S. Savchenko SI «Institute of Nephrology NAMS of Ukraine»
  • M. Kolesnyk SI «Institute of Nephrology NAMS of Ukraine»
Keywords: lactobacilli, intestine, antibacterial drugs, hyperoxaluria.

Abstract

The aim of our study was to evaluate a risk reduction of indigenous gut microbiota in patients with urinary tract infection (UTI, associated with the intake of antibacterial medicinal products

Materials and methods. To this retrospective cohort case-control study were involved 233 women with UTI. The mean age in the patient population was 36.7 ± 15.6 years. Cases were defined as reducing the number of Lactobacillus spp. < 10 million colony forming units in 1 g offeces (mln. CFU/g). We evaluated the daily urinary oxalate excretion and bacteriological seeding feces. Investigational antibiotics were medicines which are generally used to treat the outpatient with UTI.

Results. The data analysis demonstrated an extremely high risk the reducing of Lactobacillus spp. colonization in the patient’s intestine. The use of ciprofloxacin was significantly associated with an availability of hyperoxaluria ( = 0.31,

p = 0.008).

Conclusions. Thus, the use of antibacterial medicinal products, even in prophylactic doses, by the patients with UTI leads to the destruction of the normal composition of gut microbiota, and, primarily, due to the fact that the content of Lactobacillus spp. is deceased.

Downloads

Download data is not yet available.

References

Barr-Beare E. The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits (Electronic resource) / Barr-Beare E., Saxena V., Hilt E. E., [et al.] // Sands JM, ed. PLoS ONE. - 2015. – V. 10 (10). – Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598009

Bejaoui M, Sokol H, Marteau P. Targeting the mi- crobiome in inflammatory bowel disease: critical evaluation of current concepts and moving to new horizons. Digest Dis 2015;33(Suppl 1):105-12.

Chen P. Correlation between urinary stones and urinary tract infections / Chen P., Zhang L., Meng B. // Zhonghua Liu Xing Bing Xue Za Zhi. – 2014. – V. 35 (5). – P. 597-599.

Francino MP. Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. Frontiers in Microbiology. 2015;6:1543. doi:10.3389/fmicb.2015.01543. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709861/

Jandhyala S. M. Role of the normal gut microbiota / Jandhyala S. M., Talukdar R., Subramanyam C., Vuyyuru H., [et al] // World Journal of Gastroenterology : WJG. - 2015. - V. 21 (29). - P. 8787-8803.

Jernberg C. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota / Jernberg C., L fmark S., Edlund C., Jansson J. K. // ISME J. - 2007. - V. 1. - P. 56-66.

Jakobsson H. E. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome (Electronic resource) / Jakobsson H. E., Jernberg C., Andersson A. F., Sjölund-Karlsson M., [et al.] // PLoS One. 2010. - Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844414

Jäger S. Inflammatory bowel disease: an impaired barrier disease / Jäger S., Stange E. F., Wehkamp J. // Langenbecks Arch Surg. - 2013. - V. 398 (1). - P. 1-12.

Jorge Cervantes. Use your antibiotics wisely. Consequences to the intestinal microbiome FEMS Microbiology Letters May 2016, 363 (10) http://femsle.oxfordjournals.org/content/363/10/ fnw081.long#F2

Mikkelsen KH, Frost M, Bahl MI, et al. Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism. Buchowski M, ed. PLoS ONE. 2015; 10( 11):e0142352. doi:10.1371/jour- nal.pone. 0142352. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643023/

Panda S. Short-term effect of antibiotics on human gut microbiota (Electronic resource) / Panda S., Elkhader I., Casellas F., Lopez Vivancos J., [et al.] // PLoS One. - 2014. - V. 9 (4). - Mode of access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991704

Ying-Ying Wu. Toll-Like Receptor Stimulation Induces Nondefensin Protein Expression and Reverses Antibiotic-Induced Gut Defense Impairment / Ying-Ying Wu,a Ching-Mei Hsu,a Pei-Hsuan Chen,b Chang-Phone Fung // Infect Immun. 2014 May; 82(5): 1994-2005.


Abstract views: 381
PDF Downloads: 142
Published
2017-06-01
How to Cite
Stepanova, N., Stashevska, N., Lebid, L., Savchenko, S., & Kolesnyk, M. (2017). ANTIBIOTIC- ASSOCIATED RISK THE REDUCTION OF LACTOBACILLUS SPP. IN THE INTESTINAL MICROBIOTA IN PATIENTS WITH URINARY TRACT INFECTIONS. Ukrainian Journal of Nephrology and Dialysis, (2(54), 23-26. https://doi.org/10.31450/ukrjnd.2(54).2017.05

Most read articles by the same author(s)

1 2 > >>